Company Overview

Ambalal Sarabhai Enterprises Limited (Scrip Code: 500009) has filed comprehensive disclosures including its 48th Annual General Meeting notice and consolidated financial results for FY 2025-26.

AGM Details and Corporate Actions

The 48th Annual General Meeting will be held on July 30, 2026 at 11:00 AM IST entirely through Video Conferencing/Audio-Visual Means. Key agenda items include:

  • Adoption of standalone and consolidated audited financial statements for FY 2025-26
  • Reappointment of Mr. Kartikeya V. Sarabhai as Executive Chairman with monthly remuneration of ₹3.47 lakhs basic salary plus allowances
  • Reappointment of Ms. Chaula M. Shastri as Whole-time Director with monthly remuneration of ₹2.03 lakhs basic salary
  • Reappointment of Mr. Mohal K. Sarabhai as Managing Director with token salary of ₹1 per month
  • Approval for loans/guarantees/security up to ₹10 crores each to subsidiaries Synbiotics Limited, Asence Pharma Private Limited, and Systronics India Limited
  • Continuation of Mr. Govindprasad Namdeo as Non-Executive Independent Director after attaining age 75 years

Financial Performance Highlights

Consolidated Results (₹ in Lakhs)

  • Revenue from Operations: ₹20,227.17 (FY25: ₹19,618.53) - 3.1% growth
  • Profit Before Tax: ₹1,850.64 (FY25: ₹483.36) - 283% increase
  • Profit After Tax: ₹1,780.32 (FY25: ₹493.11) - 261% increase
  • Earnings Per Share: ₹2.32 (FY25: ₹0.64)
  • Total Assets: ₹28,112.87 lakhs (FY25: ₹27,167.51 lakhs)

Segment Performance

  • Pharmaceuticals: ₹11,050.62 lakhs revenue
  • Electronics: ₹9,176.55 lakhs revenue

Subsidiaries Performance

Key subsidiaries include Synbiotics Ltd (Revenue: ₹2,104.16 lakhs, Profit: ₹157.07 lakhs), Systronics India Ltd (Revenue: ₹9,419.54 lakhs, Profit: ₹549.06 lakhs), and Asence Pharma Pvt Ltd (Revenue: ₹7,638.57 lakhs, Loss: ₹129.12 lakhs).

Corporate Structure and Governance

The Board consists of 10 members including executive and independent directors. The company has 8 subsidiaries, 2 joint ventures, and 1 associate. Promoter holding stands at 31.36% with public holding at 68.64%.

Key Audit Matters and Contingencies

Uncertain tax positions remain a key audit focus with total disputed demands of ₹674.47 lakhs (Income Tax), ₹514.62 lakhs (Sales Tax), and ₹120.28 lakhs (Service Tax). Contingent liabilities total ₹1,306.64 lakhs for claims not acknowledged as debts.